These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26115542)

  • 1. Metabolomics analysis identifies novel plasma biomarkers of cystic fibrosis pulmonary exacerbation.
    Laguna TA; Reilly CS; Williams CB; Welchlin C; Wendt CH
    Pediatr Pulmonol; 2015 Sep; 50(9):869-77. PubMed ID: 26115542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis.
    Laguna TA; Williams CB; Brandy KR; Welchlin-Bradford C; Moen CE; Reilly CS; Wendt CH
    J Cyst Fibros; 2015 May; 14(3):334-40. PubMed ID: 25456770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma metabolomics in adults with cystic fibrosis during a pulmonary exacerbation: A pilot randomized study of high-dose vitamin D
    Alvarez JA; Chong EY; Walker DI; Chandler JD; Michalski ES; Grossmann RE; Uppal K; Li S; Frediani JK; Tirouvanziam R; Tran VT; Tangpricha V; Jones DP; Ziegler TR
    Metabolism; 2017 May; 70():31-41. PubMed ID: 28403943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive metabolic profiles between Cystic Fibrosis mutational subclasses and lung function.
    Masood A; Jacob M; Gu X; Abdel Jabar M; Benabdelkamel H; Nizami I; Li L; Dasouki M; Abdel Rahman AM
    Metabolomics; 2021 Jan; 17(1):4. PubMed ID: 33394183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum metabolomics indicate altered cellular energy metabolism in children with cystic fibrosis.
    Joseloff E; Sha W; Bell SC; Wetmore DR; Lawton KA; Milburn MV; Ryals JA; Guo L; Muhlebach MS
    Pediatr Pulmonol; 2014 May; 49(5):463-72. PubMed ID: 23847148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic Evaluation of Neutrophilic Airway Inflammation in Cystic Fibrosis.
    Esther CR; Coakley RD; Henderson AG; Zhou YH; Wright FA; Boucher RC
    Chest; 2015 Aug; 148(2):507-515. PubMed ID: 25611918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of Early Detection of Cystic Fibrosis Acute Pulmonary Exacerbations by Exhaled Breath Condensate Metabolomics: A Pilot Study.
    Zang X; Monge ME; McCarty NA; Stecenko AA; Fernández FM
    J Proteome Res; 2017 Feb; 16(2):550-558. PubMed ID: 28152602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.
    Lechtzin N; West N; Allgood S; Wilhelm E; Khan U; Mayer-Hamblett N; Aitken ML; Ramsey BW; Boyle MP; Mogayzel PJ; Goss CH
    Contemp Clin Trials; 2013 Nov; 36(2):460-9. PubMed ID: 24055998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic Fibrosis Rapid Response: Translating Multi-omics Data into Clinically Relevant Information.
    Cobián Güemes AG; Lim YW; Quinn RA; Conrad DJ; Benler S; Maughan H; Edwards R; Brettin T; Cantú VA; Cuevas D; Hamidi R; Dorrestein P; Rohwer F
    mBio; 2019 Apr; 10(2):. PubMed ID: 30992350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of treatment of cystic fibrosis pulmonary exacerbations on systemic inflammation.
    Sagel SD; Thompson V; Chmiel JF; Montgomery GS; Nasr SZ; Perkett E; Saavedra MT; Slovis B; Anthony MM; Emmett P; Heltshe SL
    Ann Am Thorac Soc; 2015 May; 12(5):708-17. PubMed ID: 25714657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Detection of Cystic Fibrosis Acute Pulmonary Exacerbations by Exhaled Breath Condensate Metabolomics.
    Zang X; Monge ME; Gaul DA; McCarty NA; Stecenko A; Fernández FM
    J Proteome Res; 2020 Jan; 19(1):144-152. PubMed ID: 31621328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients.
    Yang J; Eiserich JP; Cross CE; Morrissey BM; Hammock BD
    Free Radic Biol Med; 2012 Jul; 53(1):160-71. PubMed ID: 22580336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics profiling of tobacco exposure in children with cystic fibrosis.
    Wisniewski BL; Shrestha CL; Zhang S; Thompson R; Gross M; Groner JA; Uppal K; Ramilo O; Mejias A; Kopp BT
    J Cyst Fibros; 2020 Sep; 19(5):791-800. PubMed ID: 32487493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sputum desmosine during hospital admission for pulmonary exacerbation in cystic fibrosis.
    Laguna TA; Wagner BD; Luckey HK; Mann SA; Sagel SD; Regelmann W; Accurso FJ
    Chest; 2009 Dec; 136(6):1561-1568. PubMed ID: 19567495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D for the Immune System in Cystic Fibrosis (DISC): a double-blind, multicenter, randomized, placebo-controlled clinical trial.
    Tangpricha V; Lukemire J; Chen Y; Binongo JNG; Judd SE; Michalski ES; Lee MJ; Walker S; Ziegler TR; Tirouvanziam R; Zughaier SM; Chesdachai S; Hermes WA; Chmiel JF; Grossmann RE; Gaggar A; Joseph PM; Alvarez JA
    Am J Clin Nutr; 2019 Mar; 109(3):544-553. PubMed ID: 30793177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of inflammation in cystic fibrosis pulmonary exacerbations.
    Houston CJ; Taggart CC; Downey DG
    Expert Rev Respir Med; 2020 Sep; 14(9):889-903. PubMed ID: 32544353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptoms.
    Regelmann WE; Schechter MS; Wagener JS; Morgan WJ; Pasta DJ; Elkin EP; Konstan MW;
    Pediatr Pulmonol; 2013 Jul; 48(7):649-57. PubMed ID: 22949088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary desmosine: a biomarker of structural lung injury during CF pulmonary exacerbation.
    Laguna TA; Wagner BD; Starcher B; Luckey Tarro HK; Mann SA; Sagel SD; Accurso FJ
    Pediatr Pulmonol; 2012 Sep; 47(9):856-63. PubMed ID: 22431382
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.